Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,484,588
-$3,566 QoQ
Shares Held
9,783
-3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.66%
of 13F equity value
Holder Rank
#2,166
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. JNJ ranks #2 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,484,588 | 9,783 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,488,154 | 10,179 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,140,069 | 10,341 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,878,119 | 10,129 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,486,257 | 9,730 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,378,462 | 8,312 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $598,003 | 4,135 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $459,926 | 2,838 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $431,610 | 2,953 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $553,348 | 3,498 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $570,847 | 3,642 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $567,241 | 3,642 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $632,120 | 3,819 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $596,595 | 3,849 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $667,737 | 3,780 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $596,264 | 3,650 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $654,301 | 3,686 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $683,221 | 3,855 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $681,885 | 3,986 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $586,729 | 3,633 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $648,087 | 3,934 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $773,266 | 4,705 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $768,171 | 4,881 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $1,129,254 | 7,585 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $1,214,902 | 8,639 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $1,148,043 | 8,755 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||